13F Filings History of Adamant Biomedical Investments AG

Latest 13F report
Q4 2014 - 13 Feb 2015
Value $
$418,361,000
Signature - Title
Dr. Cyrill Zimmerman - CEO
Location
Zurich, Switzerland
Summary
This page shows a list of all the recent 13F filings made by Adamant Biomedical Investments AG. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Adamant Biomedical Investments AG reported 101 stock holdings with total value $418,361,000 as of Q4 2014. Top holdings included CELG, BIIB, GILD, AMGN, and B108PS.

Notify me when Adamant Biomedical Investments AG files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q4 2014 101 $418,361,000 +$52,406,702 -$73,516,974 -$21,110,272 CELG, BIIB, GILD, AMGN, B108PS 13F-HR 13 Feb 2015, 16:29
Q3 2014 96 $390,656,000 $0 $0 $0 GILD, CELG, BIIB, AMGN, B108PS 13F-HR 14 Nov 2014, 15:18
Q2 2014 0 $0 13F-NT 07 Aug 2014, 10:04
Q1 2014 0 $0 13F-NT 29 Apr 2014, 11:31
Q4 2013 0 $0 13F-NT 03 Feb 2014, 15:46